Revolution Medicines, Inc. (RVMD)
$188.44-2.84%Close
SELLRECOVERY · day 11
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $40.1B
- Beta
- 1.40
- P/E (TTM)
- -21.27
- Short % float
- 6.27%
- Days to cover
- 4.7
- SI change
- +23.3%
- 1W
- -5.72%
- 1M
- -8.13%
- vs SPY 1W
- -5.58%
- vs SPY 1M
- -10.63%
Industry peers
FMP comparable companies · ranked by market cap
- ERASSELLErasca, Inc.$5.4BRECOVERYQ 4$15.46-4.40%
- RLAYSELLRelay Therapeutics, Inc.$3.8BRECOVERYQ 2$17.41-3.45%
- TNGXSELLTango Therapeutics, Inc.$3.7BRECOVERYQ 23$22.57-8.07%
- IDYASELLIDEAYA Biosciences, Inc.$3.4BBEARQ 25$36.06-4.99%
- ELVNSELLEnliven Therapeutics, Inc.$2.9BCRISISQ 11$40.63-3.31%
- NRIXSELLNurix Therapeutics, Inc.$2.3BBEARQ 11$22.21-0.14%
- ORICSELLORIC Pharmaceuticals, Inc.$1.2BBEARQ 3$12.03-4.23%
- GLUESELLMonte Rosa Therapeutics, Inc.$872MCRISISQ 7$10.32-5.99%
- VSTMBUYVerastem, Inc.$713MRECOVERYQ 4$8.11-9.70%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on RVMD?
- LOPJLB’s latest quantitative signal on Revolution Medicines, Inc. (RVMD) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is RVMD in?
- Revolution Medicines, Inc. (RVMD) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Revolution Medicines, Inc. (RVMD) do?
- Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and color…